BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 18, 2015
View Archived Issues
Yabao Pharmaceutical and Primary Peptides to collaborate on peptide therapeutics for stroke
Read More
AntriaBio confirms new product candidate, AB-301, for type 2 diabetes
Read More
EnGeneIC to begin U.S. phase I study of (EGFR)-EDV-dox
Read More
Otsuka launches Olanedine antiseptic
Read More
Aerie Pharmaceuticals reports phase III efficacy data for Rhopressa
Read More
New mutation in LYRM7 gene associated with complex III deficiency
Read More
Nurix collaborates with Celgene on therapies to modulate protein homeostasis
Read More
AB Science's masitinib receives FDA orphan drug designation for gastric cancer
Read More
Ajinomoto patents MOGAT2 inhibitors
Read More
Arizona State University discloses RXR agonists
Read More
Toray Industries reports development of ROR-gamma antagonists
Read More
Memorial Sloan Kettering and Illumina collaborate on circulating tumor DNA
Read More
British scientists develop CDK7 inhibitors
Read More
Janssen Pharmaceutica synthesizes CB1 inverse agonists
Read More
Mitobridge signs sponsored research agreement for its PPARdelta modulators
Read More
New malaria vaccine trial shows lack of efficacy
Read More
Proof-of-concept study shows promise of novel antimalarial KAF-156
Read More
Amgen agrees to acquire TA-8995 developer Dezima Pharma
Read More
Prolyl oligopeptidase inhibitor shows promise for cognitive deficit associated with schizophrenia
Read More
Ignyta starts phase I trial of RXDX-107 in patients with solid tumors
Read More
Dimension Therapeutics' hemophilia B gene therapy receives FDA fast track designation
Read More
Phase I/IIa results presented for ChAd-EBO-Z Ebola vaccine
Read More
FDA grants orphan drug designation to sephin-1 for the treatment of Charcot-Marie-Tooth disease
Read More
Hypoglycemia may be detected by analyzing exhaled breath
Read More
FDA awards fast track designation to Can-Fite's CF-102 for hepatocellular carcinoma
Read More
Ventrix initiates phase I trial of VentriGel in patients following myocardial infarction
Read More
FDA approves Vraylar for bipolar disorder and schizophrenia
Read More